Angiotensin-(1-7)
Showing 1 - 25 of >10,000
Hypertension, Hypertension, Essential Trial in Nashville (Angiotensin (1-7), Trimethaphan, Phenylephrine)
Active, not recruiting
- Hypertension
- Hypertension, Essential
- Angiotensin (1-7)
- +2 more
-
Nashville, TennesseeVanderbilt University
Jan 2, 2023
Obesity Trial in Hershey (Angiotensin-(1-7), Saline)
Recruiting
- Obesity
- Angiotensin-(1-7)
- Saline
-
Hershey, PennsylvaniaPenn State Milton S. Hershey Medical Center
Dec 1, 2022
Aging Trial in Hershey (Angiotensin-(1-7), Saline)
Not yet recruiting
- Aging
- Angiotensin-(1-7)
- Saline
-
Hershey, PennsylvaniaPenn State Milton S. Hershey Medical Center
Jul 12, 2022
DMD-Associated Dilated Cardiomyopathy Trial in Jerusalem, Ramat Gan (talfirastide)
Recruiting
- DMD-Associated Dilated Cardiomyopathy
-
Jerusalem, Israel
- +1 more
Aug 31, 2023
Angiotensin/Renin/Aldosterone Hypertension, Hypertension, Diabetes, Type 2 Trial in Seongnam (Olmesartan)
Recruiting
- Angiotensin/Renin/Aldosterone Hypertension
- +2 more
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National University Bundang Hospital
Aug 16, 2022
Obesity, Insulin Resistance, Hypertension Trial in Nashville (Angiotensin-(1-7), Saline)
Recruiting
- Obesity
- +3 more
- Angiotensin-(1-7)
- Saline
-
Nashville, TennesseeVanderbilt University School of Medicine
Jan 18, 2022
Covid19 Trial in Stanford (Angiotensin-(1-7), Placebo)
Withdrawn
- Covid19
- Angiotensin-(1-7)
- Placebo
-
Stanford, CaliforniaStanford University
Feb 15, 2022
Infection, Coronavirus, Respiratory Failure Trial in Belo Horizonte (Angiotensin-(1-7), Placebo)
Completed
- Infection, Coronavirus
- Respiratory Failure
- Angiotensin-(1-7)
- Placebo
-
Belo Horizonte, Minas Gerais, Brazil
- +1 more
Nov 8, 2021
Coronavirus, Respiratory Failure, Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere Trial (Angiotensin 1-7,
Not yet recruiting
- Coronavirus
- +3 more
- Angiotensin 1-7
- Placebos
- (no location specified)
Jul 30, 2021
Chronic Heart Failure, Cognitive Impairment Trial in Tucson (Angiotensin-(1-7), Memory Training)
Suspended
- Chronic Heart Failure
- Cognitive Impairment
- Angiotensin-(1-7)
- Memory Training
-
Tucson, ArizonaUniversity of Arizona Sarver Heart Center
Jul 23, 2021
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Recruiting
- Hypertension
- +17 more
-
Winston-Salem, North CarolinaWake Forest Health Sciences
Jan 3, 2023
COVID-19 Trial in Istanbul (Biological/Vaccine: Angiotensin peptide (1-7) derived plasma)
Completed
- COVID-19
- Biological/Vaccine: Angiotensin peptide (1-7) derived plasma
-
Istanbul, TurkeyKanuni Sultan Suleyman Training and Research Hospital
Mar 30, 2022
COVID-19 Trial in Haifa (Angiotensin 1-7)
Recruiting
- COVID-19
- Angiotensin 1-7
-
Haifa, IsraelRambam Medical Center
Jan 18, 2021
Autonomic Nervous System Disorders, Pure Autonomic Failure, Shy-Drager Syndrome Trial in Nashville (Angiotensin-(1-7), Saline)
Terminated
- Autonomic Nervous System Disorders
- +3 more
- Angiotensin-(1-7)
- Saline
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 8, 2021
Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure NYHA Class IV Trial in Phoenix, Tucson (Angiotensin
Not yet recruiting
- Heart Failure NYHA Class II
- +2 more
- Angiotensin 1-7
- Saline solution
-
Phoenix, Arizona
- +1 more
Apr 12, 2022
Coronary Artery Bypass Surgery, Cognitive Impairment Trial in United States (Angiotensin-(1-7), Placebo for Angiotensin-(1-7))
Suspended
- Coronary Artery Bypass Surgery
- Cognitive Impairment
- Angiotensin-(1-7)
- Placebo for Angiotensin-(1-7)
-
Phoenix, Arizona
- +4 more
Nov 4, 2020
Coronavirus Disease(COVID)-19 Acute Respiratory Distress
Recruiting
- COVID
- Acute Respiratory Distress Syndrome
- Angiotensin II
- Interleukin-1 receptor antagonist
-
London, United KingdomGuy's & St Thomas' Hospital
Aug 3, 2021
Covid19 Trial in Kinshasa (Tomeka®, "Vernonia amygdalina")
Unknown status
- Covid19
- Tomeka®
- "Vernonia amygdalina"
-
Kinshasa, Congo, The Democratic Republic of theCliniques Universitaires de Kinshasa
Sep 2, 2020
Chronic Kidney Diseases Trial (Placebo, Vitamin K 2)
Not yet recruiting
- Chronic Kidney Diseases
- Placebo
- Vitamin K 2
- (no location specified)
Jul 4, 2023
COVID-19 Acute Respiratory Distress Syndrome Trial in London (VO2 Max test)
Enrolling by invitation
- COVID-19 Acute Respiratory Distress Syndrome
- VO2 Max test
-
London, Ontario, CanadaExercise Nutrition Laboratory, Western University
Jul 12, 2022
Hypertension Trial in Carrollton (Determine the presence of Human sequence Ang-(1-12) on no medication, Human sequence
Recruiting
- Hypertension
- Determine the presence of Human sequence Ang-(1-12) on no medication
- Human sequence Ang-(1-12) on Lisinopril 40mg every day
-
Carrollton, TexasPunzi Medical Center
Dec 6, 2022
Liver Transplant; Complications, Vasoplegia Trial in San Francisco (Angiotensin II, Saline)
Recruiting
- Liver Transplant; Complications
- Vasoplegia
- Angiotensin II
- Saline
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 29, 2022
Therapeutic Drug Use for CKD Patients
Active, not recruiting
- Chronic Kidney Disease
- angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
-
Jinan, Shandong, ChinaXiao Li，MD
Apr 18, 2023
Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,
Terminated
- Double Cord Blood Transplant
- +8 more
- TXA127 300 mcg/kg/day
- TXA127 1000 mcg/kg/day
-
Houston, TexasMD Anderson Cancer Center
Dec 7, 2020
COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II
Recruiting
- COVID-19
- Cardiovascular Diseases
- Angiotensin converting enzyme inhibitor
- Angiotensin II Receptor Blockers
-
Maceio, Alagoas, Brazil
- +30 more
Jan 13, 2023